S100A9 and Alzheimer disease: In this SMCI patient the S100A9 immunopositive plaques not reactive with Aβ antibodies constituted 34% of all plaques (Fig. 4M), while in AD patients these numbers were 1 and 6%, the latter corresponded to AD patient with TBI history.